- Home
- TLS vs BIOA Comparison
TLS vs BIOA Comparison
Compare TLS & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLS | BIOA |
|---|---|---|
| Founded | 1969 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.6M | 443.9M |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | TLS | BIOA |
|---|---|---|
| Price | $4.37 | $19.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $7.75 | ★ $33.33 |
| AVG Volume (30 Days) | 652.7K | ★ 796.4K |
| Earning Date | 03-09-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $144,400,000.00 | $5,917,000.00 |
| Revenue This Year | $52.26 | N/A |
| Revenue Next Year | $19.65 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.44 | N/A |
| 52 Week Low | $1.83 | $2.88 |
| 52 Week High | $8.36 | $24.00 |
Technical Indicators
Market Signals| Indicator | TLS | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 32.27 | 58.52 |
| Support Level | $4.23 | $19.31 |
| Resistance Level | $5.12 | $20.75 |
| Average True Range (ATR) | 0.30 | 1.26 |
| MACD | -0.11 | -0.27 |
| Stochastic Oscillator | 11.18 | 50.94 |
Price Performance
Historical ComparisonAbout TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.